Healthcare, Pharma & Life Sciences

Mumbai – October 30, 2026 -- The U.S. Food and Drug Administration has approved Sun Pharma's supplemental Biologics License Application for ILUMYA (tildrakizumab-asmn) in adults with active psoriatic arthritis (PsA), the first expansion of the IL-23 inhibitor beyond plaque psoriasis since its 2018 U.S. approval.

Approval addresses a U.S. patient pool of about 2.4 million

Approximately 2.4 million Americans live with PsA, according to Sun Pharma. The company states that roughly 1 in 3 people with psoriasis also have PsA, and that more than 15% of psoriasis patients may have undiagnosed PsA.

ILUMYA was previously cleared only for adults with moderate-to-severe plaque psoriasis who are candidates for systemic therapy or phototherapy.

Seattle – October 30, 2026 -- Millennium Dental Technologies, Inc. said 49% of active U.S. members of the American Academy of Periodontology (AAP) are now trained in its LANAP protocol, a laser-based alternative to traditional osseous surgery for moderate to severe periodontitis. The company announced the figure at the AAP Annual Meeting in Seattle.

Adoption reaches roughly half of active U.S. periodontists in the AAP

The company, which developed LANAP and manufactures the PerioLase MVP-7 variable-pulsed Nd:YAG dental laser, said both periodontists and general dentists are adopting the protocol. LANAP is available only with the PerioLase MVP-7, which ties each new trained clinician to the company's hardware platform.

Founder, President and Chairman Robert H. Gregg II, DDS, said the milestone matters because "patients have greater access to care they can feel comfortable accepting."

DIEBURG – October 30, 2026 -- POLYTECH Health & Aesthetics, which operates in more than 90 countries, and the London Regenerative Institute (LRI) have formed a worldwide partnership to advance adipose tissue-based techniques in aesthetic and reconstructive surgery.

Partnership pairs POLYTECH's global reach with LRI's processing know-how

POLYTECH contributes an international commercial infrastructure, long-standing relationships with plastic and reconstructive surgeons, and a hands-on training model. LRI, a clinician-led institute, contributes research and development in adipose tissue processing, regenerative protocols and structured clinical training.

The companies say fat grafting is increasingly used beyond traditional volume restoration, including refinement procedures and applications focused on tissue quality and regeneration. They add that the techniques are gaining importance in both surgical and office-based settings.

Devon, Pa. – October 30, 2026 -- Recovery Centers of America (RCA) has appointed Kendall Keller, its Enterprise Director of Licensing and Regulatory, to the Joint Commission's Behavioral Health Care and Human Services Advisory Council for a two-year term running through summer 2028.

Keller oversees compliance across 17 RCA locations in 10 states

Keller brings 18 years of experience in healthcare quality, compliance and risk management. At RCA, she manages licensing, accreditation and regulatory compliance for all 17 locations in 10 states.

She also supports RCA's expansion by researching regulatory requirements for new ventures. She secures the licenses, accreditations and registrations needed to launch new programs, service lines and sites.

Tustin – October 30, 2026 -- Avid Bioservices, a U.S. mid-scale biologics contract development and manufacturing organization (CDMO), has received the City of Tustin's Business Recognition Award in the Industrial & Manufacturing – Life Sciences category.

Tustin council member presents award to Avid CEO Kenneth Bilenberg in October 2026

Council Member Ryan Gallagher presented the award to Bilenberg, Group President and CEO of Avid, in the city where the company was founded. Avid describes the recognition as affirmation of its role in strengthening domestic biologics supply and setting the standard for flexible capacity.

Avid's local teams advance biologics from process development through commercial supply. The company provides integrated cell line development, process development, analytical development and CGMP manufacturing, from DNA to IND through commercial supply.

SAN DIEGO – October 30, 2026 -- QuidelOrtho Corporation (Nasdaq: QDEL) released episode 62 of its Science Bytes podcast, in which a senior executive argues that AI cannot deliver reliable insights in clinical laboratories until underlying lab data is standardized, reliable and traceable.

The episode features Rodney Guzman, Vice President of Software Engineering for Global Informatics Platforms at QuidelOrtho, and is hosted by Josh Casey. Guzman outlines how structured informatics can turn results from discrete laboratory systems into clinical knowledge.

Labs face rising test volumes, specialist shortages and siloed data

Laboratories are dealing with growing complexity and testing demand, according to the discussion. Lab data has historically sat in silos, and labs need ways to integrate it to speed clinical decision-making. Workforce shortages compound the problem, particularly specialists who manage complex testing scenarios.

NEW YORK – October 30, 2026 -- Concurrence, the healthcare data and AI company formerly known as Amigo, has made its Health World Model and AI agents available on Microsoft Marketplace, with eligible purchases counting toward customers' Microsoft Azure Consumption Commitment (MACC).

Deployment runs inside the customer's existing Azure environment

The platform deploys directly into a healthcare organization's Azure environment with no data migration required. It can run in the customer's own Azure subscription or in a dedicated Concurrence-managed Azure subscription in the customer's region. Health systems, biopharma companies and public health organizations on Azure keep their existing governance controls.

Concurrence is interoperable with Epic on Azure. For organizations using Microsoft Fabric, it extends the existing data foundation to power AI across clinical and operational workflows.

BOSTON – October 30, 2026 -- Nearly 150 million Americans now live in areas with unhealthy air quality, according to a new issue brief from nonprofit consultancy FSG that urges funders and policymakers to back community-led respiratory health programs.

The brief, titled "Improving Community Respiratory Health: Place-Based Lessons from the Field," was released in recognition of Lung Health Day. It draws on research and interviews with leaders from community-based organizations, philanthropy, healthcare and advocacy groups.

Six elements define effective place-based respiratory models

FSG identifies six common characteristics of successful models:

YORK – October 30, 2026 -- HR HealthCare, a family-owned U.S. medical technology company, has established the HR HealthCare Foundation as a separate charitable organization to formalize its giving across three defined focus areas.

The York, Pennsylvania-based company develops, manufactures and supplies healthcare products with integrated technology and support services. The Foundation gives its existing charitable activity a dedicated structure, with the stated aim of expanding support over time.

Foundation targets three funding areas: Dreams, Healthcare Initiatives and Community Initiatives

The "Dreams" program will create experiences for individuals living with life-altering health conditions and disabilities, and for their families.

Amsterdam – October 29, 2026 -- Lapsi Health, the Dutch clinical AI company behind the Keikku platform, has appointed Fabia Tetteroo-Bueno, former Senior Vice President and General Manager of Philips Latin America, to its Board of Directors. She will guide Lapsi's strategy and partnerships as Keikku scales across the region.

First woman to lead Philips in Latin America joins the board

Born in Brazil, Tetteroo-Bueno built her career across three continents at Royal Philips. In 2020 she became head of Philips Latin America, the first woman to lead the company in the region, and steered its healthcare strategy through the COVID-19 pandemic. She later held senior global commercial roles, including Head of Global Sales for the Software business.